Literature DB >> 3861897

Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues.

D B Herrmann.   

Abstract

Susceptibility of eight different cell types of murine or human origins to alkyl lysophospholipid analogue (ALP)-induced cytolysis correlated well with a selective, dose-dependent inhibition of radiolabeled oleic acid incorporation into phosphatidylcholine (PC) and a concomitant stimulation of incorporation into neutral lipids (NL), mainly triacylglycerols. In resistant cells (murine macrophages, L929S, K562, and rMeth A) a counts per minute NL/counts per minute PC ratio of 0.8-1.0 was observed with 30 micrograms ALP/ml; in sensitive tumor targets (Meth A, HL60, YAC, and ABLS-8.1) values greater than 2.7 were found with 5-10 micrograms ALP/ml. Changes in lipid metabolism preceded cytolysis in Meth A fibrosarcoma cells. In degradation experiments the percentage of total lipid radioactivity in PC was reduced after 24 hours to 47% compared to that in controls in sensitive Meth A with 10 micrograms ALP/ml. The macrophage-PC was unaffected at the same concentration. Sensitivity to ALP was independent of cell proliferation. Resistance was not restricted to normal cells and was inducible in Meth A (and rMeth A).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861897

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Authors:  K S Ishaq; M Capobianco; C Piantadosi; A Noseda; L W Daniel; E J Modest
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

3.  Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients.

Authors:  D B Herrmann; H A Neumann; W E Berdel; M E Heim; M Fromm; D Boerner; U Bicker
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

4.  Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment.

Authors:  N Marschner; J Kötting; H Eibl; C Unger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Pharmacokinetics of the thioether phospholipid analogue BM 41.440 in rats.

Authors:  D B Herrmann; E Besenfelder; U Bicker; W Pahlke; E Böhm
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

6.  Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.

Authors:  D B Herrmann; H A Neumann
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

7.  Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.

Authors:  J Storch; P G Munder
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

8.  Ether lipids inhibit the effects of phorbol diester tumor promoters.

Authors:  L W Daniel; L A Etkin; B T Morrison; J Parker; S Morris-Natschke; J R Surles; C Piantadosi
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

9.  Antitumor activity of Ilmofosine (BM 41.440) in the 3Lewis-lung carcinoma model.

Authors:  D B Herrmann; H G Opitz; P G Munder
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

10.  Comparison of selective cytotoxicity of alkyl lysophospholipids.

Authors:  W R Vogler; A C Olson; S Okamoto; M Shoji; R L Raynor; J F Kuo; W E Berdel; H Eibl; J Hajdu; H Nomura
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.